Browsing by Author Fountzilas, G.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 11 to 30 of 168 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group studySkarlos, D. V.; Aravantinos, G.; Kosmidis, P.; Pavlidis, N.; Gennatas, K.; Beer, M.; Mylonakis, N.; Makrantonakis, P.; Klouvas, G.; Karpathios, S.; Linardou, H.; Konstantaras, C.; Fountzilas, G.24-Nov-2015-
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A.24-Nov-2015-
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyAravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A.24-Nov-2015-
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group StudyBriasoulis, E.; Kalofonos, H.; Bafaloukos, D.; Samantas, E.; Fountzilas, G.; Xiros, N.; Skarlos, D.; Christodoulou, C.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical featuresPentheroudakis, G.; Kostadima, L.; Fountzilas, G.; Kalogera-Fountzila, A.; Klouvas, G.; Kalofonos, C.; Pavlidis, N.24-Nov-2015-
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology GroupEconomopoulos, T.; Psyrri, A.; Dimopoulos, M. A.; Kalogera-Fountzila, A.; Pavlidis, N.; Tsatalas, C.; Nikolaides, C.; Mellou, S.; Xiros, N.; Fountzilas, G.24-Nov-2015-
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?Pentheroudakis, G.; Briasoulis, E.; Karavassilis, V.; Fountzilas, G.; Xeros, N.; Samelis, G.; Samantas, E.; Pavlidis, N.24-Nov-2015-
Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer TrialsKosmidis, P. A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D.24-Nov-2015-
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology GroupPectasides, D.; Samantas, E.; Fountzilas, G.; Briasoulis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A.; Kalofonos, H. P.; Economopoulos, T.; Syrigos, K.24-Nov-2015-
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology GroupPapageorgiou, E. S.; Tsirigotis, P.; Dimopoulos, M.; Pavlidis, N.; Fountzilas, G.; Papageorgiou, S.; Economopoulos, T.24-Nov-2015-
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancerSamantas, E.; Skarlos, D. V.; Pectasides, D.; Nicolaides, P.; Kalofonos, H.; Mylonakis, N.; Vardoulakis, T.; Kosmidis, P.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II studyKosmidis, P.; Fountzilas, G.; Baka, S.; Samantas, E.; Dimopoulos, A. M.; Gogas, H.; Skarlos, D.; Papacostas, P.; Boukovinas, J.; Bakogiannis, C.; Pantelakos, P.; Athanasiou, H.; Misailidou, D.; Tsekeris, P.; Pavlidis, N.24-Nov-2015-
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology GroupKosmidis, P.; Mylonakis, N.; Dimopoulos, A.; Pavlidis, N.; Fountzilas, G.; Samantas, E.; Dimitriadis, K.; Kalophonos, C.; Tsavdaridis, D.; Skarlos, D.24-Nov-2015-
Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II StudyBriasoulis, E.; Tsavaris, N.; Fountzilas, G.; Athanasiadis, A.; Kosmidis, P.; Bafaloukos, D.; Skarlos, D.; Samantas, E.; Pavlidis, N.24-Nov-2015-
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group StudyFountzilas, G.; Polichronis, A.; Katsohis, K.; Gennatas, K.; Toussis, D.; Skarlos, D.; Kosmidis, P.; Vassilaros, S.; Semoglou, C.; Giannakakis, T.; Fahantidis, E.; Klouvas, G.; Tsavaris, N.; Konstantaras, C.; Makrantonakis, P.; Kolotas, C.; Zamboglou, N.; Tsiliakos, S.; Hainoglou, D.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group StudyNicolaides, C.; Fountzilas, G.; Zoumbos, N.; Skarlos, D.; Kosmidis, P.; Pectasides, D.; Karabelis, A.; Giannakakis, T.; Symeonidis, A.; Papadopoulos, A.; Antoniou, F.; Pavlidis, N.24-Nov-2015-
Do LH-RH analogues induce effects similar to tamoxifen on serum lipid parameters in premenopausal women with breast cancer? A prospective studyElisaf, M. S.; Bairaktari, E.; Nicolaides, C.; Fountzilas, G.; Tzallas, C.; Tsolas, O.; Siamopoulos, K.; Pavlidis, N.24-Nov-2015-
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II studyPentheroudakis, G.; Briasoulis, E.; Kalofonos, H. P.; Fountzilas, G.; Economopoulos, T.; Samelis, G.; Koutras, A.; Karina, M.; Xiros, N.; Samantas, E.; Bamias, A.; Pavlidis, N.24-Nov-2015-
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology GroupDimopoulos, M. A.; Bakoyannis, C.; Georgoulias, V.; Papadimitriou, C.; Moulopoulos, L. A.; Deliveliotis, C.; Karayannis, A.; Varkarakis, I.; Aravantinos, G.; Zervas, A.; Pantazopoulos, D.; Fountzilas, G.; Bamias, A.; Kyriakakis, Z.; Anagnostopoulos, A.; Giannopoulos, A.; Kosmidis, P.24-Nov-2015-
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology GroupSkarlos, D. V.; Dimopoulos, A. M.; Kosmidis, P.; Papakostas, P.; Pavlidis, N.; Bacoyiannis, C.; Kiamouris, C.; Klouvas, G.; Gogas, H.; Fountzilas, G.; Samantas, E.24-Nov-2015-